CTC Capital Management’s Abbott ABT Stock Holding History

CTC Capital Management’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,400	Closed	-$804K	–	119
2022 Q2	$804K	Buy	+7,400	New	+$840K	0.87%	27

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CTC Capital Management's ABT Position: Q3 2022 in Review

CTC Capital Management sold out of Abbott (ABT) in Q3 2022, closing a stake of 7,400 shares — an estimated $804K sold.

CTC Capital Management first reported a position in ABT in Q2 2022 and held it in 1 quarter. The position peaked at $804K in Q2 2022. 2,621 funds tracked by Wall St. Rank hold ABT as of Q3 2022.

CTC Capital Management reported no remaining Abbott position as of Q3 2022 after selling out during the quarter.
CTC Capital Management sold 7,400 Abbott shares in Q3 2022, an estimated $804K.
CTC Capital Management first reported a position in Abbott in Q2 2022 and held it in 1 quarter.
CTC Capital Management's Abbott position peaked at $804K in Q2 2022.
2,621 funds tracked by Wall St. Rank held Abbott as of Q3 2022.

Based on CTC Capital Management's 13F filing for Q3 2022, filed 20 Oct 2022.